The insider selling is trivial in size relative to market cap and likely reflects routine diversification or tax planning. No bearish read-through. Monitor next 10-Q for pipeline updates on batoclimab/IMVT-1402 — the stock's primary catalyst is clinical data, not insider trading patterns.
Price Chart
Executive Summary
Two C-suite insiders at Immunovant (CFO and CTO) sold a combined $374K in open-market sales on July 23, 2026, at $38.69 per share. Director Atul Pande also sold $60K on July 24 after exercising options. The total $433K in sales represents ~0.005% of the $8.1B market cap, which is trivial and routine — not a bearish signal despite the cluster pattern.
Key Financial Metrics
Key Facts
- CFO Tiago Girao sold 6,798 shares at $38.69 for $263K
- CTO Jay Stout sold 2,857 shares at $38.69 for $111K
- Director Atul Pande sold 1,500 shares at $39.80 for $60K after exercising options
- Total open-market sales: ~$433K, representing ~0.005% of $8.1B market cap
- No insider purchases in the cluster window
Financial Impact
Total insider sales of ~$433K, immaterial relative to $8.1B market cap
Risk Factors
- Insider selling could accelerate if clinical data disappoints
- Biotech sector risk: any pipeline setback could trigger significant downside
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IMVT-1784930474988 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $39.74 $39.12 | ▲ +1.56% | ▲ +2.16% | $27.68 (+30.35%) |
Jul 24, 2026 13w ago | Insider Cluster | $40.09 $43.32 | ▲ +8.06% | ▲ +4.76% | $27.68 (−30.96%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 15, 2026 18w ago | 144 | $33.61 $38.77 | ▲ +15.35% | ▲ +15.15% | $27.68 (−17.64%) |
May 28, 2026 21w ago | 144 | $33.30 $38.51 | ▲ +15.65% | ▲ +17.44% | $27.68 (−16.88%) |
May 20, 2026 22w ago | 8-K | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
May 20, 2026 22w ago | Press Release | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers